Browsed by
Tag: FDA

P-Cure Receives FDA Approval For Proton Therapy System For Treatment in Seated Position and Will Begin Treating Patients In Israel
P-Cure Receives FDA Approval For Proton Therapy System For Treatment in Seated Position and Will Begin Treating Patients In Israel

P-Cure Receives FDA Approval For Proton Therapy System For Treatment in Seated Position and Will Begin Treating Patients In Israel

April 3, 2023 — P-Overcome announced clearance of its Adaptive Proton Therapy Solution by the Food and drug administration for gross sales in the Usa. P-Heal, an Israel-based large-med-tech enterprise, has made cost-effective proton remedy engineering for specific cure of cancer with substantially minimized therapy connected side outcomes. Cure of most cancers with proton therapy is regarded the gold typical for managing many kinds of most cancers web sites with one of a kind clinical capabilities. Nonetheless, existing legacy engineering needs…

Read More Read More

FDA approves Pfizer’s new nasal spray treatment for migraines
FDA approves Pfizer’s new nasal spray treatment for migraines

FDA approves Pfizer’s new nasal spray treatment for migraines

The U.S. Food and Drug Administration has authorized Pfizer’s most recent drug on the migraine marketplace, Zavzpret (zavegepant) — the to start with and only migraine cure of its sort to be available in nasal spray. The drug has proven in medical trial details to offer swift ache reduction in as fast as 15 minutes for migraine sufferers, with relief lasting up to 48 several hours, Pfizer mentioned. Migraines are one of the most prevalent debilitating health care ailments, said…

Read More Read More

FDA Approves Omaveloxolone As First Treatment for Friedreich Ataxia
FDA Approves Omaveloxolone As First Treatment for Friedreich Ataxia

FDA Approves Omaveloxolone As First Treatment for Friedreich Ataxia

The FDA has approved omaveloxolone (Skyclarys), an agent developed by Reata Pharmaceuticals for the treatment of Friedreich ataxia in adults and adolescents aged 16 years and older, making it the first and only therapy approved for the indication.1 In the supporting trial data, treatment with omaveloxolone resulted in statistically significant lower modified Friedreich Ataxia Rating Scale (mFARS) scores relative to placebo at Week 48, accounting for a placebo-corrected difference between the groups of –2.41 points (P = .0138). The therapy,…

Read More Read More

FDA plans consumer study on front-of-pack labeling
FDA plans consumer study on front-of-pack labeling

FDA plans consumer study on front-of-pack labeling

Dive Temporary: Fda will do consumer research on the most productive way to connect nutritional information and facts on the front of food items packages. The agency published a recognize of the future exploration job in the Federal Register this week for remarks. Fda programs to use a contractor to offer you an on the web questionnaire to 3,000 inhabitants picked to signify unique ages, genders, instruction and backgrounds dependable with the most the latest Census outcomes. Contributors will be…

Read More Read More

Hoth Therapeutics Announces FDA Acceptance of IND Application for HT-001 for the Treatment of Cancer Disorders Associated with Epidermal Growth Factor Receptor (EGFR) Inhibitor Therapy
Hoth Therapeutics Announces FDA Acceptance of IND Application for HT-001 for the Treatment of Cancer Disorders Associated with Epidermal Growth Factor Receptor (EGFR) Inhibitor Therapy

Hoth Therapeutics Announces FDA Acceptance of IND Application for HT-001 for the Treatment of Cancer Disorders Associated with Epidermal Growth Factor Receptor (EGFR) Inhibitor Therapy

On-monitor to initiate Phase 2 demo in Q1 2023 NEW YORK, Dec. 29, 2022 /PRNewswire/ — Hoth Therapeutics, Inc. (NASDAQ: HOTH), a affected individual-focused biopharmaceutical company, these days announced that the U.S. Food stuff and Drug Administration (Food and drug administration) has accepted an Investigational New Drug (IND) software for the firm’s HT-001 therapeutic for the treatment for rash and pores and skin issues associated with epidermal growth factor receptor (EGFR) inhibitor treatment. EGFR inhibitors are critical therapeutic agents for the remedy…

Read More Read More

FDA approved a 1st-of-its-kind treatment made from human poop. What does it do?
FDA approved a 1st-of-its-kind treatment made from human poop. What does it do?

FDA approved a 1st-of-its-kind treatment made from human poop. What does it do?

For the to start with time, the Meals and Drug Administration (Food and drug administration) has accredited a therapy which is manufactured employing donated human poop, the company declared (opens in new tab) Wednesday (Nov. 30). The treatment method, termed Rebyota, includes intestine micro organism collected from the stool of healthful human donors and is permitted for the prevention of a perhaps everyday living-threatening bacterial an infection.  By administering the liquid cure into a patient’s rectum through a tube, health…

Read More Read More